Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System

被引:20
|
作者
Wefers, Christina [1 ,2 ]
Duiveman-de Boer, Tjitske [1 ]
Zusterzeel, Petra L. M. [2 ]
Massuger, Leon F. A. G. [2 ]
Fuchs, David [3 ]
Torensma, Ruurd [1 ]
Wheelock, Craig E. [3 ]
de Vries, I. Jolanda M. [1 ]
机构
[1] Radboudumc, Radboud Inst Mol Life Sci, Dept Tumor Immunol, Geert Grootepl Zuid 28, NL-6525 GA Nijmegen, Netherlands
[2] Radboudumc, Dept Obstet & Gynecol, Geert Grootepl 10, NL-6525 GA Nijmegen, Netherlands
[3] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, Scheeles Vag 2, SE-17177 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
lipid intermediates; paralyzed T cells; modified lipid metabolism; tumor microenvironment; FATTY-ACID CATABOLISM; PPAR-GAMMA AGONISTS; 9-HYDROXYOCTADECADIENOIC ACID; CELL-CYCLE; T-CELLS; MEDIATORS; IL-2; PROLIFERATION; MICROENVIRONMENT; ASSOCIATION;
D O I
10.3390/ijms19010273
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid metabolism is altered in several cancer settings leading to different ratios of intermediates. Ovarian cancer is the most lethal gynecological malignancy. Cancer cells disperse in the abdominal space and ascites occurs. T cells obtained from ascites are unable to proliferate after an antigenic stimulus. The proliferation of ascites-derived T cells can be restored after culturing the cells for ten days in normal culture medium. No pathway aberrancies were detected. The acellular fraction of ascites can inhibit the proliferation of autologous as well as allogeneic peripheral blood lymphocytes, indicating the presence of soluble factors that interfere with T cell functionality. Therefore, we analyzed 109 lipid mediators and found differentially regulated lipids in suppressive ascitic fluid compared to normal abdominal fluid. Our study indicates the presence of lipid intermediates in ascites of ovarian cancer patients, which coincidences with T cell dysfunctionality. Since the immune system in the abdominal cavity is compromised, this may explain the high seeding efficiency of disseminated tumor cells. Further research is needed to fully understand the correlation between the various lipids and T cell proliferation, which could lead to new treatment options.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Lipid mediators in immune regulation and resolution
    Gilroy, Derek W.
    Bishop-Bailey, David
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (08) : 1009 - 1023
  • [32] Integrated analysis reveals microRNA mediated immune system regulation in advanced epithelial ovarian cancer associated with clinical prognosis
    Korsunskiy, I.
    Lovecchio, J. L.
    Menzin, A. W.
    Whyte, J. S.
    Dos Santos, L.
    Liang, S.
    Bhuiya, T.
    Mason, C.
    Khalili, H.
    Shih, A.
    Gregersen, P.
    Lee, A.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 75 - 75
  • [33] Immune regulation of glucose and lipid metabolism
    Ota T.
    Diabetology International, 2017, 8 (3) : 257 - 267
  • [34] Immune editing in ovarian cancer
    Harper, S.
    Al-Atttar, A.
    Rolland, P.
    Durrant, L.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2009, 116 (10) : 1409 - 1409
  • [35] TAM Receptor Inhibition-Implications for Cancer and the Immune System
    Aehnlich, Pia
    Powell, Richard Morgan
    Peeters, Marlies J. W.
    Rahbech, Anne
    Thor Straten, Per
    CANCERS, 2021, 13 (06) : 1 - 16
  • [36] The effect of extensive surgery on the immune system in women with advanced ovarian cancer
    Brochner, A. C.
    Mikkelsen, S.
    Hegelund, I
    Mogensen, O.
    Toft, P.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2009, 53 : 74 - 74
  • [37] Protein 90K stimulates the immune system in ovarian cancer
    Zeimet, AG
    Marth, C
    Fuchs, D
    Herold, M
    Widschwendter, M
    Daxenbichler, G
    Iacobelli, S
    Dapunt, O
    GYNAKOLOGISCH-GEBURTSHILFLICHE RUNDSCHAU, 1996, 36 (01): : 44 - 45
  • [38] Immune regulation of ovarian development: programming by neonatal immune challenge
    Sominsky, Luba
    Sobinoff, Alexander P.
    Jobling, Matthew S.
    Pye, Victoria
    McLaughlin, Eileen A.
    Hodgson, Deborah M.
    FRONTIERS IN NEUROSCIENCE, 2013, 7
  • [39] How does the immune system contend with intratumoral heterogeneity in ovarian cancer?
    Nelson, Brad H.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 25 - 26
  • [40] Type of chemotherapy has substantial effects on the immune system in ovarian cancer
    Vankerckhoven, Ann
    Baert, Thaies
    Riva, Matteo
    De Bruyn, Christine
    Thirion, Gitte
    Vandenbrande, Katja
    Ceusters, Jolien
    Vergote, Ignace
    Coosemans, An
    TRANSLATIONAL ONCOLOGY, 2021, 14 (06):